Agilent Technologies (NYSE:A) Updates FY 2025 Earnings Guidance

Agilent Technologies (NYSE:A) updated its FY 2025 earnings guidance on Monday. The company provided EPS guidance of 5.540-5.610 for the period, compared to the consensus EPS estimate of 5.660. The company issued revenue guidance of $6.8 billion-$6.9 billion, compared to the consensus revenue estimate of $6.8 billion. Agilent Technologies also updated its FY25 guidance to $5.54-5.61 EPS.

Agilent Technologies Stock Up 0.5 %

Shares of NYSE:A opened at $134.50 on Tuesday. The business’s 50 day moving average is $137.82 and its 200 day moving average is $137.54. Agilent Technologies has a 12-month low of $124.10 and a 12-month high of $155.35. The stock has a market cap of $38.65 billion, a price-to-earnings ratio of 27.90, a PEG ratio of 5.89 and a beta of 1.07. The company has a quick ratio of 1.37, a current ratio of 1.78 and a debt-to-equity ratio of 0.36.

Agilent Technologies Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 22nd. Investors of record on Tuesday, December 31st will be paid a $0.248 dividend. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.24. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $0.99 annualized dividend and a yield of 0.74%. Agilent Technologies’s dividend payout ratio is presently 19.50%.

Analysts Set New Price Targets

A number of research firms recently issued reports on A. Wells Fargo & Company initiated coverage on Agilent Technologies in a research note on Tuesday, August 27th. They set an “overweight” rating and a $157.00 price objective on the stock. Bank of America upped their target price on shares of Agilent Technologies from $140.00 to $147.00 and gave the stock a “neutral” rating in a report on Thursday, August 22nd. UBS Group raised their price target on shares of Agilent Technologies from $141.00 to $150.00 and gave the company a “neutral” rating in a report on Thursday, August 22nd. Evercore ISI upped their price target on shares of Agilent Technologies from $135.00 to $145.00 and gave the stock an “in-line” rating in a report on Tuesday, October 1st. Finally, TD Cowen lifted their price objective on Agilent Technologies from $153.00 to $160.00 and gave the company a “buy” rating in a research note on Thursday, August 22nd. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat, Agilent Technologies currently has an average rating of “Moderate Buy” and an average price target of $144.36.

Insiders Place Their Bets

In other Agilent Technologies news, SVP Dominique Grau sold 9,990 shares of the company’s stock in a transaction that occurred on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the completion of the sale, the senior vice president now directly owns 40,011 shares of the company’s stock, valued at approximately $5,801,595. This represents a 19.98 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.